FAM200A expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.72149969227087E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.27379999995225E-06 |
Normal-vs-Stage2 |
1.077890E-02 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
2.6469937353113E-12 |
Stage1-vs-Stage2 |
7.903000E-01 |
Stage1-vs-Stage3 |
1.58209999989722E-07 |
Stage1-vs-Stage4 |
2.572600E-04 |
Stage2-vs-Stage3 |
5.016000E-03 |
Stage2-vs-Stage4 |
2.821700E-02 |
Stage3-vs-Stage4 |
2.770200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.50519946401562E-10 |
Normal-vs-AfricanAmerican |
1.60689999995078E-06 |
Normal-vs-Asian |
3.017600E-01 |
Caucasian-vs-AfricanAmerican |
7.987200E-01 |
Caucasian-vs-Asian |
2.753000E-01 |
AfricanAmerican-vs-Asian |
2.491400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.03830000153238E-08 |
Normal-vs-Female |
5.6986970697892E-11 |
Male-vs-Female |
4.794000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.837100E-03 |
Normal-vs-Age(41-60Yrs) |
9.38240000025736E-07 |
Normal-vs-Age(61-80Yrs) |
2.25808260978511E-12 |
Normal-vs-Age(81-100Yrs) |
5.13422637737904E-12 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.726400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.434100E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.540100E-03 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.853700E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.151300E-04 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.378000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.241800E-01 |
Normal-vs-Grade 2 |
1.175920E-04 |
Normal-vs-Grade 3 |
1.62470037423645E-12 |
Normal-vs-Grade 4 |
1.62436730732907E-12 |
Grade 1-vs-Grade 2 |
4.534600E-01 |
Grade 1-vs-Grade 3 |
3.931700E-02 |
Grade 1-vs-Grade 4 |
4.504300E-03 |
Grade 2-vs-Grade 3 |
4.08170000000263E-05 |
Grade 2-vs-Grade 4 |
1.37159994473279E-09 |
Grade 3-vs-Grade 4 |
8.954800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.48059999999883E-05 |
Normal-vs-ccB subtype |
5.58299961816999E-10 |
ccA subtype-vs-ccB subtype |
1.861560E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.08800002130272E-09 |
Normal-vs-N1 |
2.91310000000156E-06 |
N0-vs-N1 |
1.770010E-01 |
|
|